- Home
- REFR vs VTGN Comparison
REFR vs VTGN Comparison
Compare REFR & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFR
- VTGN
- Stock Information
- Founded
- REFR 1965
- VTGN 1998
- Country
- REFR United States
- VTGN United States
- Employees
- REFR N/A
- VTGN N/A
- Industry
- REFR Multi-Sector Companies
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- REFR Miscellaneous
- VTGN Health Care
- Exchange
- REFR Nasdaq
- VTGN Nasdaq
- Market Cap
- REFR 67.4M
- VTGN 72.4M
- IPO Year
- REFR N/A
- VTGN N/A
- Fundamental
- Price
- REFR $1.71
- VTGN $2.41
- Analyst Decision
- REFR
- VTGN
- Analyst Count
- REFR 0
- VTGN 0
- Target Price
- REFR N/A
- VTGN N/A
- AVG Volume (30 Days)
- REFR 25.1K
- VTGN 198.6K
- Earning Date
- REFR 11-07-2024
- VTGN 02-11-2025
- Dividend Yield
- REFR N/A
- VTGN N/A
- EPS Growth
- REFR N/A
- VTGN N/A
- EPS
- REFR N/A
- VTGN N/A
- Revenue
- REFR $1,469,616.00
- VTGN $876,000.00
- Revenue This Year
- REFR N/A
- VTGN N/A
- Revenue Next Year
- REFR N/A
- VTGN N/A
- P/E Ratio
- REFR N/A
- VTGN N/A
- Revenue Growth
- REFR 102.07
- VTGN 8.08
- 52 Week Low
- REFR $0.91
- VTGN $2.38
- 52 Week High
- REFR $2.41
- VTGN $5.86
- Technical
- Relative Strength Index (RSI)
- REFR 26.45
- VTGN 32.18
- Support Level
- REFR $1.68
- VTGN $2.38
- Resistance Level
- REFR $1.95
- VTGN $2.53
- Average True Range (ATR)
- REFR 0.09
- VTGN 0.13
- MACD
- REFR -0.01
- VTGN -0.01
- Stochastic Oscillator
- REFR 8.60
- VTGN 0.96
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.